2018-12-10 08:00:39INOV   - $13.06
0.41 (3.24%) , MOH - $132.94
-3.43 (-2.52%) 08:0012/10/18 12/1008:00 12/10/1808:00 | Inovalon to support Molina Healthcare to improve Medicaid, MedicareInovalon (INOV) and Molina Healthcare (MOH) announced an agreement to support Molina's widespread efforts to improve member care and documentation within its Medicaid, Medicare and marketplace member populations across the country. Molina entered into an agreement with Inovalon for similar work for its marketplace plans in Florida and Texas in 2017. The new agreement will expand the existing relationship to include additional Molina states and all lines of business across the enterprise. This will enhance Molina Healthcare's data analytics, member interventions, and reporting. Improved efficiencies between providers, members, and Molina support staff are expected to be realized immediately. The Inovalon agreement is part of a broader strategy to improve Molina's ability to manage clinical risk and needs assessment, which includes expanding its CareConnections program, hiring additional nurse practitioners for direct member outreach, and improving care coordination. INOV - $13.06
0.41 (3.24%) MOH - $132.94
-3.43 (-2.52%) | |
|---|
- $13.06
0.41 (3.24%) - 03/14/18
03/14/18
DOWNGRADETarget $10
Underweight With core growth slowing, Morgan Stanley downgrades Inovalon to Underweight As previously reported, Morgan Stanley analyst Ricky Goldwasser downgraded Inovalon to Underweight from Equal Weight as he believes a contract loss since September, ACA headwinds and the departure of the company's CFO could mean that a rebound may take longer than he expected with core growth slowing. Goldwasser lowered his price target on Inovalon to $10 from $15. - 03/14/18
On The Fly: Top five analyst downgrades Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Sunoco (SUN) downgraded to Sell from Neutral at Goldman Sachs with analyst Jerren Holder saying he sees downside risk to consensus estimates serving as a headwind for the shares. 2. Inovalon (INOV) downgraded to Underweight from Equal Weight at Morgan Stanley analyst Ricky Goldwasser saying he believes a contract loss since September, ACA headwinds and the departure of the company's CFO could mean that a rebound may take longer than he expected with core growth slowing. 3. Commercial Metals (CMC) downgraded to Neutral from Buy at BofA/Merrill with analyst Timna Tanners thinks rising rebar margins are reflected in valuation and trimmed his multiple to reflect near-term "normal" steel prices. 4. Ultimate Software (ULTI) downgraded to Neutral from Outperform at Wedbush with analyst Steve Koenig saying the shares are appropriately benefiting from strong execution in a healthy demand environment, supported by the company's product and market leadership in North American payroll and mid-market HCM. 5. Cleveland-Cliffs (CLF) downgraded to Sell from Hold at Vertical Group. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here. - 11/08/18
- PIPR
11/08/18
NO CHANGETarget $8
PIPR
Underweight Inovalon execution issues delaying revenue recognition, says Piper Jaffray Inovalon reported year-to-date bookings up 91% year-over-year in Q3, but execution issues are delaying revenue recognition, Piper Jaffray analyst Sean Wieland tells investors in a research note titled "Head Fake." Further, the company stopped selling software on a license basis, adds the analyst. He says Inovalon missed Q3, guided Q4 down, but guided 2019 in-line on the thesis the execution issues will be resolved by then. "Being long requires a leap of faith they fix the execution, a leap we are unable to make," writes Wieland. He reiterates an Underweight rating on Inovalon shares with an $8 price target. - 11/28/18
- KEYB
KeyBanc sees Amazon entry having little near-term impact on HCIT space The announcement that Amazon.com (AMZN) is developing Software-as-a-Service analytical tools for the U.S. healthcare industry called Amazon Comprehend Medical will likely bring a "lot of noise, but little real, near-term financial impact" to the publicly traded Healthcare Technology and Services space, KeyBanc analyst Donald Hooker tells investors in a research note. He believes companies potentially most relevant to Amazon's announcement include Allscripts Healthcare Solutions (MDRX), Cerner (CERN), Evolent Health (EVH), Inovalon Holdings (INOV), IQVIA Holdings (IQV), Medidata Solutions (MDSO), PRA Health Sciences (PRAH), Premier (PINC), and Teladoc Health (TDOC). Hooker argues that any potential success by mega-tech companies, such as Amazon, to develop useful SaaS analytical tools "could actually empower traditional HCIT and biopharma outsourcing companies." Further, he sees a number of "unique barriers" for "big data" solutions in clinical decision support and population health management. - $132.94
-3.43 (-2.52%) - 10/18/18
- MSCO
10/18/18
NO CHANGETarget $184
MSCO
Overweight Morgan Stanley ups Molina target to $184 on Wisconsin exchange re-entry odds Morgan Stanley analyst Zack Sopcak said his checks of the Molina Healthcare website increase his confidence Molina will be marketing ACA plans in Wisconsin during open enrollment. Wisconsin re-entry could add 34,000 lives and $300M to 2019 revenue, estimated Sopcak, who raised his price target on the stock to $184 from $178. He keeps an Overweight rating on Molina and expects the company to confirm whether or not it is participating in Wisconsin, as well as Utah, for 2019 on its Q3 earnings call. - 11/07/18
- MSCO
Split Congress 'best outcome' for MCOs and hospitals, says Morgan Stanley Morgan Stanley analyst Zack Sopcak contends that the Democratic party retaking the majority in the House of Representatives and Republicans retaining the Senate is the "best outcome" for Managed Care Organizations and hospitals, stating that he now sees another attempt at a repeal/replace of the Affordable Care Act as "off the table." The split Congress could also lower the volume on the "Medicare for All" debate given a lack of mandate from either the Democratic or Republican party, Sopcak tells investors. The election results remove a key overhang for Centene (CNC) and Molina (MOH), which he views as most exposed to the ACA marketplace, and to a lesser extent the hospitals, Sopcak added. With ACA repeal/replace off the table, and given the longer term potential upside from Medicaid expansion in Utah and Idaho as expansion ballot initiatives appear to be passing in both states, Sopcak said Molina is emerging as his top pick in the space heading into the final weeks of 2018. Publicly traded hospital companies include Community Health (CYH), HCA Healthcare (HCA), LifePoint (LPNT), Tenet (THC) and Universal Health (UHS). - 11/13/18
- JEFF
11/13/18
UPGRADETarget $169
JEFF
Buy Molina Healthcare upgraded to Buy from Hold at Jefferies Jefferies analyst David Windley upgraded Molina Healthcare to Buy and raised his price target for the shares to $169 from $152. - 11/13/18
- JEFF
11/13/18
UPGRADETarget $169
JEFF
Buy Jefferies upgrades Molina to Buy on confidence in earnings stability Jefferies analyst David Windley upgraded Molina Healthcare to Buy from Hold and raised his price target for the shares to $169 from $152. Despite raising earnings guidance, concern about earnings sustainability has pulled the stock down 14% from recent highs, Windley tells investors in a research note. The analyst says that while Healthcare Exchange margin pressure and reduced revenue in Florida and New Mexico are risks, Molina's cost initiatives plus organic growth "will more than offset headwinds." He views the stock's valuation as attractive at current share levels and has increased coincidence in the company's earnings stability. |